Sodium Thiosulfate Patent Expiration
Sodium Thiosulfate is Used for reducing ototoxicity in pediatric patients with localized medulloblastoma following cisplatin administration. It was first introduced by United States Army Office Surgeon General
Sodium Thiosulfate Patents
Given below is the list of patents protecting Sodium Thiosulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Pedmark | US11291728 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11510984 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11617793 | Anhydrous sodium thiosulfate and formulations thereof | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11964018 | Therapeutic uses for sodium thiosulfate formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11992530 | Therapeutic uses for sodium thiosulfate and formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US11998604 | Therapeutic uses for sodium thiosulfate formulations | Jul 01, 2039 | Fennec Pharms Inc |
| Pedmark | US10596190 | Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy | Jan 05, 2038 | Fennec Pharms Inc |
| Sodium Thiosulfate | US8496973 | Sodium thiosulfate-containing pharmaceutical compositions | Mar 29, 2031 | Hope Pharms |
| Sodium Thiosulfate | US10479686 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US9345724 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US9585912 | Sodium thiosulfate-containing pharmaceutical compositions | Jul 07, 2030 | Hope Pharms |
| Sodium Thiosulfate | US11753301 | Sodium thiosulfate-containing pharmaceutical compositions | Feb 10, 2030 | Hope Pharms |
Sodium Thiosulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List